X

Get our occasional Market Report emails

sent straight to your inbox

There’s no charge for this.

Getting latest data loading
X

Request a Call to Trade

In addition to the daily Research emails, I would also like to receive the Accendo Markets Weekly Newsletter and occasional Market Report emails highlighting various trading opportunities.
When you enter your telephone number, we may call or message you occasionally with trading opportunities. You can opt out at any time

This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.

Renishaw

A trading opportunity for you?

Will Renishaw continue falling, or will it rise again back to November high of 4406p?

  • Renishaw shares have fallen over 20% from November’s 4406p highs
  • Shares falling on the news that competitor Smiths Group will split its Medical division, creating more competition.
  • Renishaw manufactures healthcare measurement systems.
  • Currently trading at 3667p (at time of writing).
  • Shares -36.9% from 2018 highs; +1.4% from 2018 lows; -30% year-to-date.
  • Recent share price range: Nov highs 4406p; now trading close to Oct-Nov lows.
  • Can the stock recover to November highs?
  • Source: Dow Jones, Bloomberg, FT, Company News

Click to enlarge

Trading Renishaw – An Example

Let’s say you feel that the stock is a bargain and you think it could bounce back to recent highs of 4406p. You decide to buy exposure to £10,000 worth of Renishaw using a CFD, at the current price of 3667p. To do this, you need £2,000.

Let’s assume Renishaw recovers back to 4406p November levels (+20.1%). Your profit would be £1960, from your initial investment of £2000.

Conversely, let’s assume you open the above position, and place a stop-loss at 8% from the current price. Renishaw falls 8% and hits your stop-loss. Your loss would be £800.

This is provided for information purposes only. It should not be taken as a recommendation.

This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.


Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.

Prepared by Michael van Dulken, Head of Research
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
.